Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability-Reference-Cited by-同舟云学术

Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability

Published:2024-09 Issue: Volume:158 Page:109906
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Allard Jon,Henley William,Sellers Adrian,O’Shaughnessy Emma,Thomson Oliver,McLean Brendan^ORCID,Parrett Mary,Rajakulendran Sanjeev,Watkins Lance,Maguire Melissa^ORCID,Ellawela Shan,Tittensor Phil^ORCID,Sen Arjune,Mohanraj Rajiv,Bagary Manny^ORCID,Ram Sunil,Brown Allan^ORCID,Shankar Rohit^ORCID

Funder

UCB

UCB Pharma Ltd

National Institutes of Health

National Institute for Health and Care Research

Publisher

Elsevier BV

Reference37 articles.

1. Prevalence of epilepsy among people with intellectual disabilities: A systematic review;Robertson;Seizure,2015

2. People with learning disability and autistic people (LeDeR) report for 2022;White,2022

3. Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study;Kinnear;BMJ Open,2018

4. Royal College of Psychiatrists. Management of Epilepsy in Adults with Intellectual Disability (CR203); 2017.

5. Awareness, attitudes, skills and training needs of psychiatrists working with adults with intellectual disability in managing epilepsy;Lines;Seizure,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brivaracetam in patients with and without intellectual disability: Who benefits most and who tolerates it best?;Epilepsy & Behavior;2024-10

2. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review;Expert Review of Neurotherapeutics;2024-08-19